Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

N. Plevris (Lead / Corresponding author), C. S. Chuah, R. M. Allen, I. D. Arnott, P. N. Brennan, S. Chaudhary, A. M. D. Churchhouse, S. Din, E. Donoghue, Daniel R. Gaya, M. Groome, H. M. Jafferbhoy, P. W. Jenkinson, W. L. Lam, M. Lyons, J. C. Macdonald, M. MacMaster, C. Mowat, G. D. Naismith, L. F. PottsE. Saffouri, J. P. Seenan, A. Sengupta, P. Shasi, D. I. Sutherland, J. A. Todd, J. Veryan, A. J. M. Watson, David Watts, G. R. Jones, C. W. Lees

    Research output: Contribution to journalArticlepeer-review

    38 Citations (Scopus)
    283 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science